Literature DB >> 7731751

Activation of the neutrophil bactericidal activity for nontypable Haemophilus influenzae by tumor necrosis factor and lymphotoxin.

A M Tan1, A Ferrante, D H Goh, D M Roberton, A W Cripps.   

Abstract

Previous studies have suggested that, in vivo, activated T lymphocytes and neutrophils are important in immunity to nontypable Haemophilus influenzae. We now extend this work by showing that neutrophils pretreated with products of activated T lymphocytes or activated macrophages show significantly enhanced killing of nontypable H. influenzae. Lymphotoxin, a product of activated T lymphocytes, significantly enhanced the neutrophil-mediated killing of nontypable H. influenzae, and tumor necrosis factor, produced by activated T lymphocytes as well as macrophages stimulated by activated T lymphocytes, also significantly increased the bactericidal activity of neutrophils. These cytokine-induced effects were seen with short pretreatment times of neutrophils and were maximal by 30 min. The killing of H. influenzae by neutrophils required the presence of heat-labile opsonins. In the absence of these opsonins, both tumor necrosis factor and lymphotoxin were unable to promote the killing of the bacteria by neutrophils. Furthermore, the results showed that tumor necrosis factor-primed neutrophils displayed significantly increased expression of CR3 and CR4 that was associated with increased phagocytosis of complement-opsonized nontypable H. influenzae. These cytokines may play an important role in immunity toward nontypable H. influenzae by stimulating neutrophil bactericidal activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7731751     DOI: 10.1203/00006450-199502000-00005

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

1.  Opsonization and phagocytosis of Plasmodium falciparum merozoites measured by flow cytometry.

Authors:  L M Kumaratilake; A Ferrante
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

2.  Intrapulmonary delivery of tumor necrosis factor agonist peptide augments host defense in murine gram-negative bacterial pneumonia.

Authors:  L L Laichalk; K A Bucknell; G B Huffnagle; J M Wilkowski; T A Moore; R J Romanelli; T J Standiford
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

Review 3.  Role of cytokines in pulmonary antimicrobial host defense.

Authors:  B Mehrad; T J Standiford
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

4.  Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia.

Authors:  L L Laichalk; S L Kunkel; R M Strieter; J M Danforth; M B Bailie; T J Standiford
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

Review 5.  Immune defence mechanisms and immunoenhancement strategies in oropharyngeal candidiasis.

Authors:  Cristina Cunha Villar; Anna Dongari-Bagtzoglou
Journal:  Expert Rev Mol Med       Date:  2008-10-13       Impact factor: 5.600

6.  Tumor necrosis factor-alpha/interleukin-10 balance in normal and cystic fibrosis children.

Authors:  G V Shmarina; A L Pukhalsky; S N Kokarovtseva; D A Pukhalskaya; L A Shabalova; N I Kapranov; N J Kashirskaja
Journal:  Mediators Inflamm       Date:  2001-08       Impact factor: 4.711

7.  Galectin-1 is required for the regulatory function of B cells.

Authors:  R Alhabbab; P Blair; L A Smyth; K Ratnasothy; Q Peng; A Moreau; R Lechler; R Elgueta; G Lombardi
Journal:  Sci Rep       Date:  2018-02-09       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.